Tallarico, Demetrio <br/><br/>
Myocardial cytoprotection by trimetazidine against anthracycline-induced cardiotoxicity in anticancer chemotherapy.  [electronic resource] 

 -  Angiology   
 - 219-27 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Controlled Clinical Trial; Journal Article 
<br/><br/><label>ISSN: </label>0003-3197 
<br/><br/><label>Standard No.: </label>10.1177/000331970305400212  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Antibiotics, Antineoplastic--adverse effects<br/>Antineoplastic Agents--adverse effects<br/>Breast Neoplasms--drug therapy<br/>Cardiovascular Agents--therapeutic use<br/>Diastole--drug effects<br/>Female<br/>Heart--drug effects<br/>Humans<br/>Middle Aged<br/>Razoxane--therapeutic use<br/>Trimetazidine--pharmacology<br/>Vasodilator Agents--pharmacology